7 results
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
of 20–60 mg/kg Chronic ... daily for 28 days Chronic ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
with acute, early-chronic ... for Acute, Early Chronic ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
weeks followed by chronic ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS
Treating Isospora belli Infection
General Management Considerations:
 • Fluid
Infection General Management ... BID for 7 days Chronic ... Discontinuation of Chronic ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS
IDSA Recommendations for Preventing and Managing Cryptosporidiosis in HIV-AIDS
Preventing Chronic Cryptosporidiosis:
 • Because chronic cryptosporidiosis occurs
HIV-AIDS Preventing Chronic ... Cryptosporidiosis: • Because chronic ... disease Preferred Management ... Alternative Management ... opportunistic #infections #HIVAIDS
IDSA Recommendations for Preventing and Managing Microsporidiosis in HIV-AIDS
Preventing Chronic Microsporidiosis:
 • Because chronic microsporidiosis occurs
HIV-AIDS Preventing Chronic ... Microsporidiosis: • Because chronic ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
Therapy Followed by Chronic ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS